Furthermore, Bcl-2 has also been linkedwith several human cancers.11,12 Due to the pivotalrole of Bcl-2 in regulating/inhibiting apoptosis, the Bcl-2 proteinis a strategic and potent target for the development of novel anticanceragents for various cancers.4 Hence, Bcl-2inhibitors are considered remarkable therapeutic targets for cancertherapy. This evidence concerns the gene BCL2 and cancer.